Camber Capital Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.6M | Sell |
400,000
-850,000
| -68% | -$11.9M | 0.53% | 20 |
|
|
2025
Q1 | $17M | Sell |
1,250,000
-1,000,000
| -44% | -$13.6M | 0.6% | 21 |
|
|
2024
Q4 | $45.9M | Buy |
2,250,000
+250,000
| +13% | +$5.1M | 1.06% | 17 |
|
|
2024
Q3 | $58.3M | Hold |
2,000,000
| – | – | 1.85% | 17 |
|
|
2024
Q2 | $46.4M | Buy |
2,000,000
+500,000
| +33% | +$11.6M | 1.29% | 19 |
|
|
2024
Q1 | $30.8M | Buy |
+1,500,000
| New | +$30.8M | 0.75% | 21 |
|